Contract 75A50119C00055
Albert B. Sabin Vaccine Institute, Inc. (The) · Department Of Health And Human Services · September 1, 2021
Albert B. Sabin Vaccine Institute, Inc. (The) was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 1, 2021 for $37.01 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Washington, DC. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on July 23, 2024. If all options are exercised, the contract could reach $149.75 million.
Contract details
- PIID
- 75A50119C00055
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- R&D- Medical: Specialized Medical Services (Advanced Development)
- Place of performance
- Washington, DC
- First action
- September 1, 2021
- Latest action
- July 23, 2024
Description
ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.
Modification timeline
-
July 23, 2024Mod P00020 · Supplemental Agreement For Work Within Scope$147.06M
-
September 1, 2021Mod P00004 · Exercise An Option$75.11M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50119C00055?
Contract 75A50119C00055 is a federal contract awarded to Albert B. Sabin Vaccine Institute, Inc. (The) by Department Of Health And Human Services on September 1, 2021 for $37.01 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50119C00055?
Albert B. Sabin Vaccine Institute, Inc. (The) won contract 75A50119C00055 from Department Of Health And Human Services.
How much is contract 75A50119C00055 worth?
Contract 75A50119C00055 has obligated $37.01 million to date, with a total potential value of $149.75 million if all options are exercised.